All-Wales COPD Management and Prescribing Guideline – ICST

All-Wales COPD Management and Prescribing Guideline

Endorsed by the All Wales Medicines Strategy Group (AWMSG) and the Respiratory Health Implementation Group (RHIG), the All-Wales COPD Management and Prescribing guideline standardises the diagnostic process, and provides a consistent approach to care in Wales. The aim of this guideline is to optimise the greatest-value interventions for COPD which will help to reduce exacerbations and hospital admissions and save millions of pounds through correct inhaler prescribing.

Key Recommendations:
  • Identify objective evidence for a diagnosis of COPD
  • Refer for smoking cessation therapy, flu vaccination, pulmonary rehabilitation, and oxygen assessment
  • Categorise a patient according to their phenotype, to guide inhaled therapy

Related Education

The COPD Annual Review

Categorise the patient into three COPD phenotypes

Referral for high value interventions

Confirming a diagnosis of COPD


Global Strategy for the Diagnosis, Management and Prevention of COPD

NICE Quality Standard: Chronic obstructive pulmonary disease in adults

The QALY Pyramid

Diagnosis and management of COPD in primary care

© Institute of Clinical Science and Technology (ICST) 2020